The ER and HER2 signaling pathways play vital roles in promoting cell proliferation in breast cancer (Cheskis et al., 2007; Seshacharyulu et al., 2012; Yarden and Pines, 2012; Saczko et al., 2017). Here, ESR1 is linked to breast carcinoma.